[MYGN] QoQ Quarter Result on 31-Mar-2017 [#Q1]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
03-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -28.81%
YoY- -87.12%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Revenue 194,000 190,200 200,500 196,900 196,500 177,500 186,500 2.65%
PBT 3,700 86,600 18,800 8,000 12,100 4,000 37,300 -78.48%
Tax -28,400 5,600 6,100 3,800 6,200 5,200 13,900 -
NP 32,100 81,100 12,900 4,200 5,900 -1,200 23,400 23.38%
Tax Rate 767.57% -6.47% -32.45% -47.50% -51.24% -130.00% -37.27% -
Total Cost 161,900 109,100 187,600 192,700 190,600 178,700 163,100 -0.48%
Ratio Analysis
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
NP Margin 16.55 42.64 6.43 2.13 3.00 -0.68 12.55 20.19%
Per Share
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
EPS 0.46 1.18 0.19 0.06 0.09 -0.02 0.33 24.70%
EPS Diluted 0.45 1.15 0.19 0.06 0.09 -0.02 0.32 25.44%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.